Consegna Pharma
Manufacturing · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2403 Sidney St Ste 255, Pittsburgh, Penn...Phone Number
(412) 213-8788Website
www.consegnapharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Consegna Pharma
Consegna Pharma Inc. is a specialty pharmaceutical company focused on developing long-acting medications, particularly for opioid overdose reversal. Their lead product, CP216, is designed to release naloxone over 12-24 hours, addressing the risk of renarcotization in overdose victims. The company aims to provide effective solutions to combat the opioid crisis, which has resulted in significant fatalities in the United States. Their intended clients include healthcare providers and organizations involved in addiction treatment and emergency response.Explore more
Consegna Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Consegna Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Consegna Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Consegna Pharma is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Consegna Pharma
Check if Consegna Pharma has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Consegna Pharma has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Consegna Pharma recently announced quarterly report
Click to see if Consegna Pharma had a recent Job posting/layoffs
Product Launch: Get notified when Consegna Pharma launches new products
Recommended Actions
Reach out to Masked Content who joined Consegna Pharma as Masked Content
Find 3 more new buyers
Compare Similar Companies to Consegna Pharma
Compare insights from companies similar to Consegna Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Consegna Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Consegna Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Consegna Pharma.
Consegna Pharma financials insights
Gather financial insights about Consegna Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$29K
Consegna Pharma Tech Stack
A closer look at the technologies used by Consegna Pharma
Most Recent Scoops
Funding
Project
Spending/Investment
Mergers & Acquisitions (M&A)
Mergers & Acquisitions
Funding
Consegna Pharma has received an SBA PPP loan in the amount of $29,622 from PNC Bank resulting in the retention of 2 jobs.
Funding
Consegna Pharma News & Media
Consegna Pharma Acquires Fathom Pharma
Consegna Pharma Inc., a drug delivery company providing solutions to reduce deaths from opioid overdoses, is pleased to announce the... Read More The post Consegna Pharma Acquires Fathom Pharma appeared first on citybiz.Consegna Pharma Acquires Fathom Pharma to Strengthen Initiatives that Address the Opioid Crisis
The acquisition adds breadth to Consegna's mission to save lives by developing innovative products to treat overdose, addiction, and pain. PITTSBURGH, April 19, 2022 /PRNewswire/ -- Consegna Pharma Inc., a drug delivery company providing solutions to reduce deaths from opioid overdoses,...Consegna Pharma Receives NIH Research Grant to Develop CP216, a Sustained-Release Naloxone Treatment for Opioid Overdose Reversal
Long-acting naloxone can potentially help to prevent renarcotization. (PRWeb December 18, 2019) Read the full story at https://www.prweb.com/releases/consegna_pharma_receives_nih_research_grant_to_develop_cp216_a_sustained_release_naloxone_treatment_for_opioid_overdose_reversal/prweb16792597.htm
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Consegna Pharma
Sign Up For FreeTo access detailed company insights
Consegna Pharma Inc. is a specialty pharmaceutical company focused on developing long-acting medications, particularly for opioid overdose reversal. Their lead product, CP216, is designed to release naloxone over 12-24 hours, addressing the risk of renarcotization in overdose victims. The company aims to provide effective solutions to combat the op... Read More
